Create an injection molding supplier scorecard by scoring evidence against the specific part and program, not by ranking sales claims or the lowest quote. Use weighted criteria for technical fit, injection molding quality control, process validation, lead-time planning, commercial clarity, and communication. Give every bidder the same RFQ package, record the proof behind each score, and treat the result as a controlled decision record that is updated after trials or production changes.
A scorecard is not a certification check or a promise of performance. It is a repeatable way to expose which supplier has demonstrated a credible route to making this part under the buyer’s stated conditions.
01
H2: Start with the part and program risk
A supplier scorecard should answer one buying question: which candidate has shown the most credible, controllable way to make this part for this program? Start by defining the decision boundary before inviting scores. Include the approved 3D model and drawing revision, material or permitted alternatives, annual and release-volume assumptions, critical-to-quality features, cosmetic zones, packaging needs, required secondary operations, destination market, and approval route. These inputs keep a low-risk commodity housing from being evaluated with the same emphasis as a thin-wall, glass-filled, cosmetic, safety-related, or insert-molded part.
Translate risk into criteria. A tight datum scheme may make measurement capability more important than press count. Moisture-sensitive resin makes drying records and lot traceability central. An uncertain forecast needs transparent capacity planning, not an unqualified injection molding lead-time promise. First decide whether a supplier is technically and operationally eligible; then compare eligible suppliers on value and risk. A low offer or quality certificate does not by itself prove control of the submitted geometry, resin, finish, and volume pattern.
02
H2: Use a weighted, evidence-based comparison
Set a simple 0-to-5 evidence scale for every criterion: 0 means no answer or a material gap; 1 means a general claim; 3 means part-relevant documents, examples, and a stated method; and 5 means part-relevant evidence that can be traced, discussed with the responsible function, and checked during a review. Calculate weighted points as criterion weight multiplied by evidence score divided by 5. Do not hide a disqualifying safety, regulatory, confidentiality, or ownership condition inside a total score; flag it separately as a pass, fail, or open risk.
The table is a comparison template, not a claim that any named supplier has a particular capability. Record the evidence reference beside each score, such as a DFM report revision, sample measurement report, control plan, trial record, or written clarification. This allows engineering, quality, procurement, and the receiving site to challenge the same facts instead of debating impressions.
| Scorecard area and suggested weight | Supplier A | Supplier B | Supplier C | Comparable evidence to request |
|---|---|---|---|---|
| Technical fit — 25% | Record 0–5 and evidence ID | Record 0–5 and evidence ID | Record 0–5 and evidence ID | Part-specific DFM, gate and cooling rationale, material-processing plan, tooling concept |
| Quality and validation — 25% | Record 0–5 and evidence ID | Record 0–5 and evidence ID | Record 0–5 and evidence ID | Inspection plan, CTQ method, measurement-system approach, sample and validation route |
| Delivery and supply continuity — 15% | Record 0–5 and evidence ID | Record 0–5 and evidence ID | Record 0–5 and evidence ID | Milestone plan, capacity assumptions, material route, contingency and escalation path |
| Commercial and tooling control — 15% | Record 0–5 and evidence ID | Record 0–5 and evidence ID | Record 0–5 and evidence ID | Quote inclusions, exclusions, revision assumptions, ownership, maintenance and change terms |
| Program management and communication — 10% | Record 0–5 and evidence ID | Record 0–5 and evidence ID | Record 0–5 and evidence ID | Named contacts, response workflow, issue log, document control and meeting cadence |
| Responsible sourcing and export readiness — 10% | Record 0–5 and evidence ID | Record 0–5 and evidence ID | Record 0–5 and evidence ID | Packaging proposal, shipment documentation scope, traceability and applicable compliance evidence |
03
H2: Test technical fit before scoring capacity claims
Ask each bidder to respond to the same technical questions. The response should identify likely filling, venting, shrinkage, warpage, ejection, cosmetic, and tolerance risks, plus the assumptions behind the proposed mold concept. A usable DFM response is specific about the submitted model revision and explains what needs buyer action, what will be confirmed during trials, and what remains uncertain. Generic statements that a part is moldable are weak evidence because they do not identify the decision path.
For injection molding quality control, look for an inspection plan tied to the drawing and the part’s CTQs. Clarify the datum reference, sampling stage, gauge or CMM approach, reaction to an out-of-control result, nonconforming-material segregation, and record retention needed by the buyer. For multi-cavity tooling, request a plan to identify cavity-specific variation where it is relevant. The aim is not to impose a universal inspection level; it is to determine whether the proposed controls can detect the risks the part actually carries.
Review injection molding process validation as process understanding, documented trial or qualification evidence, and routine monitoring. FDA presents validation as a lifecycle approach, although its regulated scope is not a default requirement for every molded part. Apply the logic proportionately: define settings and limits, critical checks, approval evidence, and triggers for review. In automotive work, PPAP is a structured example of showing production-rate parts meet engineering records and specifications; use the customer-required process rather than assuming PPAP is universal. References 2 and 3 provide context.
04
H2: Compare cost and lead time as assumptions, not promises
A scorecard should expose the cost logic behind an injection molding quote. Compare the stated resin grade and color, mold scope, cavities, runner concept, cycle-time assumption, scrap or runner treatment, secondary operations, inspection, packaging, logistics term, duties or taxes if quoted, and change allowances. When scope differs, normalize it or list the difference as an open commercial risk. A lower unit price can be based on a different material route, a different tooling scope, fewer controls, or excluded work; it is not automatically a lower total program cost.
Use the same discipline for injection molding lead time. Ask for milestone assumptions from design freeze through DFM review, tool design, build, trial, sample measurement, corrections, approval, first shipment, and repeat releases. Then ask what depends on buyer response time, material availability, freight mode, holiday calendars, tooling changes, and approved samples. Record a range or a planning sequence only when the supplier explains its basis. Do not score a shorter stated date above a more credible plan with identified dependencies.
For Europe, the United States, and the Middle East, review drawing units and languages, time-zone coverage, labeling, packaging protection, shipment records, and export-document ownership. Score these only where they affect receiving, regulatory, service, or traceability requirements.
05
H2: Govern the scorecard after selection
Freeze the initial decision record with the RFQ revision, attendees, evidence list, weights, scores, assumptions, open actions, and approval date. ISO describes ISO 9001 as a quality-management framework for consistent products and services; for supplier management, the useful practice is documented, repeatable evaluation rather than treating a certificate as a blanket approval. Reference 1 is a starting point for that quality-management context.
Revisit the score after DFM, first-trial measurement, before first shipment, and when material, tooling, process, facility, sub-supplier, inspection, or commercial scope changes. Keep delivery performance, nonconformance response, corrective-action effectiveness, and communication records in the controlled file. If candidates are close, present the tied criteria, remaining risks, and a specific action to close the evidence gap rather than forcing false precision.
06
H2: Use the RFQ to collect comparable proof
Request a quote only after attaching the scorecard inputs and asking each supplier to return answers in the same structure. Ask for named technical, quality, and commercial owners; a part-specific DFM response; tooling and trial scope; validation and inspection proposal; lead-time assumptions; quote inclusions and exclusions; ownership and change-control terms; and a list of open questions. This makes injection molding sourcing auditable and reduces the chance that a comparison becomes a comparison of incompatible assumptions.
Use the RFQ response to begin a technical conversation, not to award on a spreadsheet alone. A responsible supplier will sometimes identify uncertainty, request a tolerance clarification, or propose a staged trial. That can be stronger evidence than an unconditional claim, provided the risk, owner, decision needed, and next evidence are documented. Request a quote with your CAD, drawing, forecast range, material requirements, CTQs, cosmetic standard, destination, and desired approval evidence so the assessment can be specific to your program.
Practical takeaway
Before you move
to the next review.
- Issue one controlled RFQ package with the same CAD and drawing revision to every bidder.
- Define CTQs, cosmetic zones, material requirements, volume pattern, destination, and approval route before assigning weights.
- Use a documented 0-to-5 evidence scale and record an evidence ID beside every supplier score.
- Separate pass-or-fail conditions and open risks from the weighted total.
- Compare quote scope and injection molding lead time assumptions line by line before comparing totals.
- Request a part-specific DFM response, inspection plan, trial plan, and change-control route.
- Assign owners and due dates to evidence gaps, then rescore after DFM, trials, and material changes.
- Retain the approved scorecard, source documents, decision rationale, and performance feedback for the next sourcing review.
FAQ
Common questions
What is the best weighting for an injection molding supplier scorecard?
There is no universal weighting. Give more weight to technical and quality evidence when geometry, material behavior, CTQs, cosmetics, or validation risk dominate. Raise the weight of delivery, export handling, or commercial control when those conditions materially affect the program. Document why the weights fit the part instead of copying a generic template.
Should ISO certification determine whether a supplier is selected?
No. Certification can be relevant evidence of a quality-management system, but it does not prove that a supplier can control the submitted part. Review current, part-specific technical, inspection, validation, delivery, and change-control evidence alongside any certification.
How should buyers score injection molding process validation?
Score the clarity and traceability of the proposed validation route. Look for identified process variables, defined acceptance evidence, trial or qualification records where appropriate, controls for routine production, and a way to react when the process or part changes. Match the depth of evidence to the part and customer requirements.
Can the lowest quote still be the preferred supplier?
Yes, if its scope, assumptions, risks, and supporting evidence are comparable and the buyer accepts the remaining exposure. The scorecard does not prohibit a lower-cost choice. It makes differences in tooling, material, inspection, logistics, and change scope visible before an award.
When should the scorecard be updated?
Update it when meaningful evidence appears or a material condition changes, including DFM completion, tool trials, first-article review, production start, quality escapes, major delivery issues, a tool modification, a process change, or a change in material or sub-supplier.
References
Source material
- [1] ISO — ISO 9001 Quality management systems — Requirements
- [2] U.S. Food and Drug Administration — Process Validation: General Principles and Practices
- [3] Automotive Industry Action Group — Production Part Approval Process
This guide is general information for early procurement and engineering discussion. It does not replace product-specific DFM, qualification, validation, regulatory assessment or legal advice.